FDA launches global operation to crack down on websites selling illegal, potentially dangerous drugs
- Details
- Category: FDA
![FDA FDA](/images/logo/fda.png)
FDA approves expanded use of Gardasil 9 to include individuals 27 through 45 years old
- Details
- Category: FDA
![FDA FDA](/images/logo/fda.png)
FDA approves first treatment for advanced form of the second most common skin cancer
- Details
- Category: FDA
![FDA FDA](/images/logo/fda.png)
FDA awards 12 grants to fund new clinical trials to advance the development of medical products for the treatment of rare diseases
- Details
- Category: FDA
![FDA FDA](/images/logo/fda.png)
FDA approves new kind of treatment for hairy cell leukemia
- Details
- Category: FDA
![FDA FDA](/images/logo/fda.png)
FDA approves first-of-its kind targeted RNA-based therapy to treat a rare disease
- Details
- Category: FDA
![FDA FDA](/images/logo/fda.png)
FDA approves treatment for two rare types of non-Hodgkin lymphoma
- Details
- Category: FDA
![FDA FDA](/images/logo/fda.png)
More Pharma News ...
- FDA approves first targeted treatment for patients with relapsed or refractory acute myeloid leukemia who have a certain genetic mutation
- FDA approves first cancer drug through new oncology review pilot that enables greater development efficiency
- FDA warns of imposters sending consumers fake warning letters
- FDA takes steps to encourage more informative labeling on prescription drug and biological products' indications and usage
- FDA approves first drug comprised of an active ingredient derived from marijuana to treat rare, severe forms of epilepsy
- FDA takes steps to foster greater efficiency in biosimilar development by reconsidering draft guidance on evaluating analytical studies
- FDA takes action against 53 websites marketing unapproved opioids as part of a comprehensive effort to target illegal online sales